GWS Medika and Parkway Cancer Centre Hold CME Talk on Breast Cancer Detection
According to the WHO, in 2022, 2.3 million women diagnosed with breast cancer, causing 670 thousand deaths worldwide. Breast cancer continues to be one of the leading causes of death, besides lung and colorectal cancers. In Indonesia, breast cancer is the most common type of cancer suffered by women, with 30.8% of cases and 20.4% of deaths in 2020.
As a form of commitment to updating the knowledge and skills of the medical team in facing health challenges, GWS Medika held a Continuing Medical Education (CME) Talk event on breast cancer with dr. Khoo Kei Siong from Parkway Cancer Center (PCC) Singapore (10/10).
In this CME session, dr. Khoo discussed "Breast Cancer Screening in Primary Care and The Role of New Emerging Modality for Cancer Screening—Detection of the Circulating Cancer DNA."
The event began with a speech by dr. Koh Hau-Tek, Chief Medical Officer and Co-Founder of GWS Medika. Furthermore, dr. Farah Ardinda, Clinic Manager and Assistant Cluster Head, moderated the session, which included a discussion and Q&A.
Next, Ibnu Subroto, a CanHOPE representative, explained Can Hope and PCC services, which provide comprehensive support for cancer survivors and their families through a multidisciplinary medical team.
The team includes specialists, nurses, counselors, and other medical professionals. CanHOPE, a non-profit PCC cancer counseling and support service, has seven branches across major cities throughout Indonesia.
In his presentation, dr. Khoo emphasized the importance of awareness that breast cancer can affect anyone, both women and men, including those who have an active and healthy lifestyle.
Breast cancer is one of the three most common cancers. Prevention and early detection are critical steps that need to be taken because they can increase life expectancy and reduce cancer mortality.
For women under 39 years old, it is recommended to do a monthly breast self-examination, while those aged 40 years and over are recommended to have an annual mammogram.
Latest information on cancer screening and treatment
A team of doctors and nurses from GWS Medika attended the CME Talk, where they learned about the importance of breast cancer screening and prevention. Advances in understanding cancer biology have resulted in developing more specific and compelling drugs.
Molecular marker scanning methods may detect multiple cancers with a single blood test. Cancer treatment will become more personalized and tailored to the patient's genetic makeup and molecular characteristics. More than one examination is usually required for cancer screening. However, early detection of cancer is often still difficult. This can be due to a lack of information, fear of the disease, or high costs.
On that occasion, dr. Kooh introduced LucenceINSIGHT, an early detection test for various types of cancer. This test can detect changes and/or viruses related to cancer and its origins and changes. However, the scan results are not a diagnosis, so further diagnostic testing is recommended.
With this CME Talk, GWS Medika is committed to updating medical personnel's knowledge and skills in the latest health challenges, including cancer screening and detection. Through this activity, GWS Medika hopes to provide better, more accurate, and more innovative health services to the community.
Trust your health to GWS Medika, a health clinic in Jakarta, where doctors and health workers continue to develop to support healthy living.
